Full-Time

Scientist/Senior Scientist

Assay Development

Confirmed live in the last 24 hours

Deadline 7/16/25
Zoetis

Zoetis

5,001-10,000 employees

Develops and sells animal health products

No salary listed

Mid, Senior

Durham, NC, USA

In Person

Category
Veterinary Professionals
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • BA/BS in a scientific discipline related to biological and chemistry assay development. Minimum of 3 years of laboratory experience in assay development in the pharmaceutical, medical device, diagnostics or related industries.
  • MA/MS in a scientific discipline related to biological and chemistry assay development. Minimum of 2 year of laboratory experience in assay development in the pharmaceutical, medical device, diagnostics or related industries.
  • BA/BS or MA/MS in a scientific discipline related to biological and chemistry assay development. Minimum of 4-6 years of laboratory experience in assay development in the pharmaceutical, medical device, diagnostics or related industries.
  • PhD in a scientific discipline related to biological and chemistry assay development. 0-2 years of laboratory experience in assay development in the pharmaceutical, medical device, diagnostics or related industries.
  • Expertise in immunoassay, chemistry, and biomarker assay development (ligand binding assays, spectrophotometry, wet chemistry).
  • Strong knowledge of biosafety protocols and safe specimen handling.
  • Excellent oral, written, and technical communication skills.
  • Proactive self-starter, able to work independently and collaboratively.
  • Strong interpersonal, problem-solving, multitasking, and organizational skills.
  • Proficient in statistical software (e.g., JMP, Prism) and Microsoft Office suite.
Responsibilities
  • Apply knowledge of molecular biology, biochemistry, and immunology in the design and execution of experiments to advance the development of new products.
  • Develop and optimize assays for diagnostic applications while maintaining the highest standards of scientific integrity and quality—always doing the right thing for the right reason.
  • Perform benchtop experiments using wet lab techniques for innovative bioassays with meticulous attention to detail and ethical standards.
  • Collaborate with systems engineers to integrate hardware, software, consumables, and assays for diagnosis and monitoring, embracing teamwork to achieve seamless solutions.
  • Work closely with cross-functional teams and contribute to a culture where everyone feels empowered to speak up and share ideas.
  • Execute product verification and validation studies to ensure assay accuracy and reproducibility meet specifications; draft protocols and reports with accountability and thoroughness.
  • Analyze data, interpret and present findings to management and stakeholders, encouraging open dialogue and feedback to promote continuous improvement.
  • Maintain accurate and detailed laboratory records reflecting our commitment to integrity and doing the right thing for the right reason.
  • Support multiple projects simultaneously and contribute to regulatory and customer documentation within a collaborative and respectful team environment.
  • Maintain laboratory spaces responsibly—including cleaning, inventory management, and equipment upkeep—showing respect for shared resources and reinforcing that teamwork makes the dreamwork.
  • Demonstrate strong emotional intelligence, including the ability to understand and manage one's own emotions, empathize with colleagues, and navigate complex interpersonal dynamics effectively.
Desired Qualifications
  • Experience translating biomarker discovery into diagnostic assay solutions.

Zoetis focuses on animal health by discovering, developing, manufacturing, and selling a variety of medicines and vaccines for animals. Their products cater to both companion animals, like dogs and cats, and livestock, including cattle and poultry. For companion animals, Zoetis offers vaccines, treatments for parasites, and skin care products. For livestock, they provide vaccines, anti-infectives, and medicated feed additives. The company stands out from competitors through its commitment to research and development, ensuring a steady stream of new and improved products. Zoetis aims to enhance animal health and well-being while supporting veterinarians and animal owners globally.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing pet telemedicine boosts Zoetis' companion animal segment.
  • Precision livestock farming enhances productivity, benefiting Zoetis' livestock segment.
  • mRNA vaccine technology offers new product development opportunities for Zoetis.

What critics are saying

  • Alternative proteins may reduce demand for traditional livestock products, impacting Zoetis.
  • Generic competition pressures Zoetis' pricing and market share.
  • Regulatory scrutiny on antibiotics could limit Zoetis' anti-infective market.

What makes Zoetis unique

  • Zoetis leads in animal health with a diverse portfolio of medicines and vaccines.
  • Strong global presence in over 100 countries enhances Zoetis' market reach.
  • Focus on innovation and R&D drives Zoetis' competitive edge in animal health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Company News

PharmaData
Jun 6th, 2025
Zoetis Highlights Environmental and Social Impact in 2024 Update

Zoetis, a global leader in animal health, has released its 2024 Sustainability Progress Update, titled "Advancing Sustainability in Animal Health for a Better Future," marking the fifth consecutive year the company has reported on its purpose-driven sustainability strategy.

Vettimes
Apr 24th, 2025
Zoetis to host VN parasitology CPD event

Zoetis to host VN parasitology CPD event.

PYMNTS
Apr 17th, 2025
How To Manage Risks When Employees Use Ai Secretly For Work

Employees who use generative artificial intelligence tools in the workplace without company approval or oversight — a practice known as “bring your own AI’ or BYOAI — could introduce risks into the enterprise, according to MIT researchers. “Make no mistake, I’m not talking theory here,” said Nick van der Meulen, a research scientist at MIT’s [] The post How to Manage Risks When Employees Use AI Secretly for Work appeared first on PYMNTS.com.

MarketBeat
Mar 11th, 2025
Clare Market Investments LLC Makes New $670,000 Investment in Zoetis Inc. (NYSE:ZTS)

Clare Market Investments LLC makes new $670,000 investment in Zoetis Inc. (NYSE:ZTS).

MarketBeat
Mar 10th, 2025
Raymond James Financial Inc. Makes New $196.65 Million Investment in Zoetis Inc. (NYSE:ZTS)

Raymond James Financial Inc. makes new $196.65 million investment in Zoetis Inc. (NYSE:ZTS).